CytoSorb therapy is indicated for the treatment of medical conditions where cytokines are excessively elevated. Hypercytokinemia is found in a variety of clinical situations and can drive systemic inflammation – a common final pathway in many acute critical illnesses. An excessive systemic immune response in any of these syndromes may result in shock, multiple organ failure and death.
CytoSorb is being used frequently in two major areas:
CytoSorb has also been used successfully in many other hyper-inflammatory conditions. Case reports on first clinical applications in some of these fields have been published or presented. These include:
The therapy is not intended to be used as a measure of last resort and is meant to be used with the appropriate standard of care therapy for the disease.